Document is current
Any future updates will be listed below
-
Authors
Coe, Genevieve L.
Krout, Ian N.
Munro-Ehrlich, Mason
Beamish, Catherine R.
Vorojeikina, Daria
Colman, Daniel R.
Boyd, Eric J.
Walk, Seth T.
Rand, Matthew D. http://orcid.org/0000-0001-7871-0895
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04060212 at ClinicalTrials.govDocuments that mention this clinical trial
Assessing the role of the gut microbiome in methylmercury demethylation and elimination in humans and gnotobiotic mice
https://doi.org/10.1007/s00204-023-03548-7
-
Funding
Funding for this research was provided by:
National Institute of Environmental Health Sciences (ES030940, ES001247, T32 207026)
- License Information
-
More Information
Article History
Received: 25 April 2023
Accepted: 14 June 2023
First Online: 1 July 2023
Declarations
:
: The authors declare there are no conflicts of interest.
: All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All human and animal studies included in this study have been reviewed and approved by the appropriate Institutional Review Boards (IRBs) of the respective institutions where the studies were conducted (Human Clinical Trials reviewed by the University of Rochester IRB and registered (NCT04060212) and mouse studies reviewed by the Montana State University IRB). All human volunteers participating in this study have given their informed consent prior to enrolling in the study.
